Bioadhesive-based dosage forms: the next generation.

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Polymer Chemistry

Background:

• Bioadhesive polymers significantly improve drug performance by extending drug-tissue contact time.
• First-generation bioadhesive polymers have demonstrated success in enhancing local treatment, bioavailability, and patient compliance over the past 15 years.
• Existing literature extensively documents the benefits of "off-the-shelf" bioadhesive polymers.

Purpose of the Study:

• To review the achievements of first-generation bioadhesive polymers in drug delivery.
• To propose next-generation bioadhesive polymers with enhanced properties.
• To outline the anticipated benefits of advanced polymeric systems in drug therapy.

Main Methods:

• Literature review of bioadhesive polymer applications in drug delivery.
• Analysis of successes attributed to first-generation bioadhesive polymers.
• Exploration of future directions and potential innovations in bioadhesive polymer design.

Main Results:

• First-generation bioadhesive polymers offer significant advantages in drug delivery, including improved therapeutic efficacy and patient compliance.
• Prolonged drug-tissue contact facilitated by bioadhesives leads to enhanced bioavailability and controlled release profiles.
• The review underscores the established value of current bioadhesive technologies.

Conclusions:

• Bioadhesive polymers represent a critical advancement in drug delivery, optimizing therapeutic outcomes.
• Next-generation bioadhesive polymers are expected to offer further improvements in drug targeting, release kinetics, and patient adherence.
• Continued innovation in bioadhesive polymer science promises to revolutionize pharmaceutical development and clinical applications.